Royal Philips has expanded the automated capabilities of its EPIQ CVx and CVxi cardiology ultrasound platforms to speed up and simplify cardiac assessments and reduce clinician interaction with the platform, the Amsterdam-based health technology conglomerate announced this week.
The updated artificial intelligence improves the EPIQ systems' automated 2D assessments and 3D measurements of right ventricle volume and ejection fraction. According to Philips, the new applications allow clinicians to accurately evaluate heart function even faster and easier than before, and with less variability between scans, increasing their diagnostic confidence in cases of pulmonary hypertension, congenital heart disease, coronary disease and heart failure.
Additionally, the new system requires fewer touches from clinicians to perform each scan: a reduction of 21 percent per exam, or the equivalent of more than 400 exams each year.
More articles about AI:
AI-guided robotic device replaces endoscopy in diagnosing colon cancer
Blackstone CEO donates $190M to Oxford for AI ethics research
Most companies spend at least $51,000 on AI, report finds: 4 notes